A Peripheral Blood Biomarker Signature Potentially Identifies Smokers with Interstitial Lung Abnormalities
Avignat S. Patel(Lahey Hospital and Medical Center), Iván O. Rosas(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Jill M. Siegfried(University of Minnesota), James A. Lederer(Brigham and Women's Hospital), Tracy J. Doyle(Brigham and Women's Hospital), Frank C. Sciurba(Pulmonary and Allergy Associates), Souheil El‐Chemaly(AVEO Oncology (United States)), Yuanyuan Shi(Jiaozuo University), Víctor Pinto-Plata(St. Elizabeth's Medical Center), María F. Golzarri(Brigham and Women's Hospital), George R. Washko(Brigham and Women's Hospital), Hiroto Hatabu(Harvard University), Joseph K. Leader(Brigham and Women's Hospital), Joel L. Weissfeld(University of Pittsburgh), Yushi Liu(Eli Lilly (United States)), Cristobal Risquez(Cornell University), Naftali Kaminski(Yale University), Yuka Okajima(St. Luke's International Hospital), Bartolomé R. Celli(Brigham and Women's Hospital), Juan Sebastian Osorio(Brigham and Women's Hospital), Mizuki Nishino Hatabu(Brigham and Women's Hospital)
Cited by 0
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856